Plain-English translation of NCT07597005 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing red propolis, a natural substance derived from bee products, to see if it can help reduce inflammation and oxidative stress in people with chronic kidney disease. Researchers believe that chronic inflammation and oxidative stress make kidney disease worse over time, so this medication may help slow disease progression. The study will measure changes in blood markers and genes related to inflammation to see if the treatment works.
People with kidney disease often develop long-lasting inflammation and oxidative stress, which can make their condition worse. There is very limited evidence about whether this medication can help, so researchers want to test it in a rigorous study to find out if it could become a useful treatment.
You likely qualify if…
You likely don't qualify if…
You will take a capsule by mouth every day for 8 weeks—either containing the medication or a placebo (inactive pill), and neither you nor the researchers will know which one you are taking. You will have blood tests at the start and end of the study to measure inflammation markers, oxidative stress, and how your kidneys are functioning. The study will also assess your nutrition and diet during this time.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Brazil
Universidade Federal Fluminense
Enrollment target
~40 participants
Started
September 2025
Primary completion
November 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 65 Years
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Denise Mafra, phd
Universidade Federal Fluminense
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.